PRM

Clinical Studies Coordinator in Houston, TX

[John A. Cuenca, MD @JohnCuencaMD]

We invite you to read our latest publication in @intensiva_med 📢

In this systematic review of septic shock RCTs, we found striking variability in how mortality timeframes are reported—making cross-trial comparisons challenging.

🔗 https://t.co/LF0MkQhggm
#Sepsis #MedTwitter

[Paola Yépez @paoyepezg]

Had an incredible time presenting at the Panama International Critical Care Congress! Grateful for the chance to share my work and connect with so many inspiring professionals. #MedicalEducation

[Paola Yépez @paoyepezg]

Hi #MedTwitter ,
I'm Paola Yepez, an Ecuadorian IMG and currently a Research Fellow at @MDAndersonNews.
I'm thrilled to apply for Internal Medicine at the #match2025 !
I'm grateful for the support from everyone along the way, and I’m excited to connect with you all.

[Nancy (she/her/ella) @Nancy76040900]

Felicidades Doctor @JohnCuencaMD!
Un gran trabajo en crear conciencia acerca de sepsis. #sepsis
https://t.co/Ni3ctTCWb5

[Journal of the @NCCN @JNCCN]

Outcomes and Predictors of 28-Day Mortality in Patients With #HematologicMalignancies and #SepticShock Defined by Sepsis-3 Criteria: https://t.co/jjKqnvrmnW #hemeonc #sepsis #SepsisAwareness
@JosephNates @nirmala_km @JohnCuencaMD @peytonrm2 @HeatterJuliana

[John A. Cuenca, MD @JohnCuencaMD]

Check out our latest publication in @JNCCN. In our cohort of hematologic cancer pts with septic shock, we found a 68% 28-day mortality.

Risk factors:
🛑 Lactate
🛑 SOFA score
🛑 Respiratory failure

Protective:
✅ Albumin
✅ Aminoglycosides
✅ G-CSF

📎 https://t.co/i4t1Uya71B

[John A. Cuenca, MD @JohnCuencaMD]

Our multilevel-intervention enhanced and promoted patient and family-centered care among critically ill cancer patients and their families @MDAndersonNews.

Interventions:
🔷Open visitation policy
🔷2-way communication boards
🔷Revamped waiting rooms

📎https://t.co/U96E0Ypo1s

[John A. Cuenca, MD @JohnCuencaMD]

Grateful for the chance to collaborate in this fascinating experiment led by Dr de Villalobos! @JosephNates @peytonrm2

🔺Hyperventilation as a “bridge” strategy in ventilated hypoxic rats.

🔺Applying the lessons from high altitude medicine.

🔗https://t.co/JZnKMdjV1S

[John A. Cuenca, MD @JohnCuencaMD]

Happy to share our meta-analysis in @yourICM! Morphine & midazolam were the most common drugs used during the withholding and withdrawing of life support in critically ill patients at the end-of-life. @JosephNates @KPMD85 @amlopezo @fowlerlibrarian

https://t.co/DBJ2HrgfAm

[Nirmala K Manjappachar @nirmala_km]

#COVID19 screening volunteers to protect our patients, visitors and employees @MDAndersonNews #DACCPM

[Tatiana Prowell, MD @tmprowell]

This is sobering. Listen then take #COVID19 #coronavirus seriously. The outcome of this pandemic, in the 🇺🇸, is going to depend on individuals & communities making choices to restrict their OWN freedom to assemble. Please do the right thing. #FlattenTheCurve #CloseTheSchools

[Yascha Mounk @Yascha_Mounk]

The Italian College of Anesthesia, Analgesia, Resuscitation and Intensive Care just published the most extraordinary medical document I’ve ever seen.

To help people from Germany to America understand what we’re about to face, I am publishing translated extracts here.

[Thread.]

[John A. Cuenca, MD @JohnCuencaMD]

Thankful with the @SCCM for giving us the opportunity to present our findings in Oncological Critical Care at the #CCC49 @MDAndersonNews @ONCCCRNET

[Nirmala K Manjappachar @nirmala_km]

Humbled to be a presenter for our Critical Care Research team at SCCM 2020 #CCC49. Together we are stronger. Excited to see the next steps to our work to #endcancer @SCCM @MDAndersonNews @KPMD85 @JosephNates @Dr_RajaReddy @ONCCCRNET @CarinHagberg #DACCPM

[PRM @peytonrm2]

Productive week in Florida with a stellar research team. #CCC49 @SCCM

[Juliana Heatter @HeatterJuliana]

Had a great experience with the Critical Care team at the #ccm49 @MDAndersonNews

[Silvio A. Ñamendys-Silva @snamendys]

#LessIsMore in the #ICU https://t.co/seoVYkIH7h

[PRM @peytonrm2]

7/7 presentations, 10/10 quality. Congratulations on a great conference @nirmala_km! @SCCM @ONCCCRNET @MDAndersonNews #CCC49

[PRM @peytonrm2]

@traumamd1 @JohnCuenca9 @SCCM @MDAndersonNews @ONCCCRNET Thank you for a great session Dr. Santos!

[John A. Cuenca, MD @JohnCuencaMD]

Immune checkpoint inhibitors weaponize the inmune system to fight tumors. Severe immune related adverse events require intensive care management @JosephNates @ONCCCRNET @SCCM #CCC49